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ABSTRACT
Study objectives: To determine whether integrating post-abortion services in hospital settingsin 
China will increase the contraceptive use and decrease repeat abortion rates. 
Study design: Three-arms cluster randomised controlled trial in which the unit of randomisation 
is hospital.
Participants: Women seeking induced abortion within 12 weeks of gestation age.
Sites: Ninety hospitals from 30 provinces in China will be randomised to the three arms of the 
study stratified by province. In each province, eligible hospitals will be matched on the character-
istics of abortion departments, especially the volume of abortions in the 2 months in the situation 
survey.
Length of follow up: Six months.
Intervention: Multiple interventions that aim to increase the use of more effective contraceptive 
methods, improve user adherence to reduce the unintended pregnancies and repeat induced abor-
tions.
Data collection: Data will be collected at four time points, one at baseline(month 0 at the time 
of enrolment) and twice during intervention (1st3rd and 6th month after enrolment, respectively).
Primary outcome: Unintended pregnancies or repeated induced abortions; immediate contracep-
tive uptake and the use of modern effective contraceptive methods.
Trial registration: International Standard Randomised Controlled Trial: ISRCTN01846583, reg-
istered on 23 October 2014.
KEY WORDS: Cluster randomised trial; Induced abortion; Contraception; Family planning; China.
ABBREVIATIONS: AU-DESC: Aarhus University – Danish Epidemiology Science Centre; CMA- 
CSFP: Chinese Society of Family Planning - Chinese Medical Association; EC: Emergency Con-
traception; FP: Family Planning; FU: Fudan University; HCo: Hospital Co-ordination; IEC: In-
formation, Education and Communication ; INPAC: INtegrating Post-Abortion family planning 
services into China’s existing abortion services in hospital settings; IUD: Intra Uterine Device; 
LSTM: Liverpool School of Tropical Medicine; NCo: National Co-ordination; NRIFP: National 
Research Institute for Family Planning; OCP: Oral Contraceptive Pills; PAC: Post Abortion Care; 
PAFP: Post-Abortion Family Planning; PCo: Provincial Co-ordination; PMT: Project Manage-
ment Team; SCU: Sichuan University; TSC: Trial Steering Committee; UG-ICRH: International 
Centre for Reproductive Health, Ghent University; WHO: World Health Orgnization; WP: Work 
Package.
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BACKGROUND AND SCIENTIFIC RATIONALE
Induced abortion in China
In China, induced abortion has increased from 10 millionin 2003 
to 13 million in 2008,1 of which one third of women have un-
dergone repeat abortions.2,3 It was estimated that direct medical 
costs for abortion were 3 billion Chinese Yuan in 2002 (326 mil-
lion euro)4 and it has been growing over time. Most abortions are 
performed in hospitals in urban areas.5,6 Social changes in China 
have led to an abortion epidemic among young and unmarried 
women at average 20-years-old, accounting for 11-55% of total 
induced  abortion according to previous studies6,7 and up to 75% 
in a recent survey of 2008.8
Rationale for intervention
The large number of induced abortions in China is primarily 
due to contraceptive failures or less/no use of contraception.9 
In China, contraceptive methods are mainly delivered through 
family planning (FP) clinics which mainly target married cou-
ples and through pharmacies. Users obtained condoms and oral 
contraceptive pills (OCP) from pharmacies mostly rely on only 
non-medical sources for advice and information or on packaging 
instructions. These instructions do not include concrete informa-
tion on contraceptive failures, nor on how to avoid them.
Abortion is a common way to terminate an unintended preg-
nancy, although social discrimination associated with abortion 
remains, especially for unmarried women.10 To our knowledge, 
the vast majority of induced abortions are performed in hospital 
settings, though family planning clinics also provide abortion 
services.11,12 Post-Abortion Family Planning (PAFP) services are 
often lacking in hospital settings and women who have under-
gone abortion are usually not referred to family planning clinics 
for FP counselling and services.8 The fragmentation of FP ser-
vices is leaving high risk to vulnerable groups such as young and 
unmarried women, as well as rural-to-urban migrant women.
Recent studies showed that non-use and poor compliance of 
contraception were common among adolescents and young 
women, which indicated lack of knowledge and poor motiva-
tion.13,14 Combination of educational and contraceptive interven-
tions appeared to reduce unintended pregnancy among adoles-
cents.15 Abortion-experienced women were more motivated than 
other women to start effective and safe contraception after an 
abortion.16 A study on PAFP conducted in three cities in China 
in 2006 has corroborated that the introduction of PAFP services 
in urban China increases the use of contraceptives methods and 
thus reduces the rates of unintended pregnancy and induced 
abortion.17 The present study will evaluate the implementation of 
FP services after induced abortion in hospital settings in a ‘real 
world’ situation covering 30 provinces in China and to assess 
effectiveness, acceptability, and sustainability of this approach.
Rationale for use of a cluster randomised trial design
Our intention is to compare integrating post-abortion services in 
hospital settings with current services provided by the hospitals. 
It is essential that the whole hospital is randomised to interven-
tion or to continue with their current practice, this will minimise 
contamination between the trial arms and will be as close as pos-
sible to real life situation. Therefore the unit of randomisation 
will be hospital.
OBJECTIVES
Overall objective of the research
This study aims to reduce unintended pregnancies and repeat 
abortions through integrating post-abortion family planning ser-
vices into existing abortion services at hospital settings in China 
in order to strengthen healthcare delivery for equitable access 
and sustainable development.
Specific scientific and technical objectives
To assess the needs and feasibility of integrating PAFP into exist-
ing abortion services at hospitals through the review of China’s 
FP policy and practice as well as strategies of delivering PAFP 
in developed and other developing countries. 
•	 To assess practicability of integrating PAFP into existing 
abortion services at study hospitals through health system 
study involving stakeholders: policy makers, health manag-
ers, abortion service providers and women who have under-
gone abortions.
•	 To develop detailed intervention strategies for improving ac-
cess to, and quality of FP services after induced abortion. 
•	 To implement and monitor intervention processes, their im-
pact on hospitals and problems incurred during the imple-
mentation.
•	 To evaluate the effectiveness of integrated PAFP regarding 
unwanted pregnancy and repeated abortion rate and to ana-
lyze health system determinants of the effectiveness through 
comparison across the intervention groups. 
•	 To bridge the gap between research and policy through in-
volving policy and decision makers at different level of gov-
ernments.
•	 To draw conclusions regarding the feasibility, effectiveness 
and sustainability of the interventions and to disseminate the 
results nationally and internationally.
TRIAL DESIGN
This is a cluster randomized controlled intervention trial.
METHODS
This protocol follows the recommendations for elaborating ran-
domised controlled trials described in the SPIRIT guideline.18
Study Setting
The study is conducted in 30 of the 31 administrative divisions 
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in mainland China (22 provinces, 4 municipalities, 4 autono-
mous regions).
Participants
Eligibility criteria for participating hospitals (cluster)
Hospital inclusion criteria was identified according to the find-
ings of a baseline situation analysis and China’s current hospital 
settings:
•	 Agreement with the randomized allocation
•	 Average number of abortions per month between 200 to 800 
•	 Willing and able to carry out the intervention packages pro-
posed by the study
•	 Availability to collect data at four time-points 
•	 Consent given for involvement within an appropriate envi-
ronment 
Hospitals that do not meet the above inclusion criteria will not 
be considered eligible to this study.
Eligibility criteria for women
Women will be eligible to be interviewed and followed-up if 
they seek abortion at participating hospitals and meet the fol-
lowing inclusion criteria (all women visiting the participating 
hospitals will receive normal services regardless of their partici-
pation conditions).
•	 Unintended pregnancies seeking induced abortion 
•	 Gestation age less than 12 weeks 
•	 Aged ≥18 and ≤40 years 
•	 Sexually active women of childbearing potential and not 
planning to become pregnant during the study
•	 No physical and mental problem that may affect subject en-
rolment or follow-up
•	 Willing to give informed consent in writing
•	 Willing and able to response the scheduled surveys and to 
comply with the study procedures
Exclusion criteria
•	 Having intention to become pregnant during the study 
INTERVENTION
Intervention packages and trial arms 
The intervention packages were developed based on the find-
ings from the situation analysis and the existing post abortion 
care (PAC) program in selected hospitals in China,19 as well as 
the World Health Organization (WHO) guidelines on preventing 
early pregnancy and safe abortion.20,21 This trial includes three-
arms: two intervention groups and one control group.
Intervention group 1: Standard PAFP Package
Training of abortion service providers and managers
● Target population: all abortion service providers (doctors or 
nurse) and department/hospital managers.
● Contents of the training: Family planning counselling knowl-
edge, delivery of contraceptive services (e.g., OCP, intra 
uterine device - IUD, implants), youth-friendly (no judge-
ment) and client-centred counselling/communication skills. 
Standard service guidelines and PAFP procedure will be de-
veloped and introduced.
● Modes of the training: The appropriate training materials 
(e.g. interactive video and booklet, group face-to-face train-
ing, workshop, remote/online training courses and all train-
ing materials at project website) will be developed in English 
and local language.
Providing relevant Information, Education and Communication 
(IEC) to women and their partners by abortion service provid-
ers
● Target population: All women seeking abortion at the partici-
pating hospitals.
● Contents of the IEC: Basic knowledge on reproductive 
health, information on the prevention of unintended preg-
nancy and sexually transmitted diseases, health risks of re-
peat abortion, the need to start contraception immediately 
after induced abortion and the management of contraceptive 
failure and emergency contraception (EC), as well as the dif-
ferent available contraceptive methods and their advantages / 
disadvantages. 
● Modes of providing the IEC: Written materials, video or au-
dio recording or group counselling at waiting (pre-abortion) 
and resting (post-abortion) areas. 
Providing individual counselling to women (and their partners) 
at pre- and post –abortion by abortion service providers 
Women and their partners who presented at the moment will be 
invited to participate in a face-to-face counselling in a recov-
ery room in a homely environment, service providers are non-
judgemental and considerate in their dealing with women (in the 
way of client-centred/ youth-friendly and personalized counsel-
ling). Service providers will understand the reason of induced 
abortion and provide the personalized recommendations and 
technical support to prevent future unintended pregnancy. This 
session will also provide psychological counselling accordingly 
and suggest referral for those who need. 
Offering modern contraceptive methods
(e.g., The modern contraceptive methods  according to the avail-
ability of participating hospitals will be offered to the women 
immediately) to the women immediately after the abortion.
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Continuous PAFP service/follow-up counselling 
•	 Continuous PAFP services will include inviting visits or 
phone calls to control the complications of abortion within 4 
weeks after the abortion (such as infection, bleeding). 
•	 And phone SMS or face-to-face counselling for those who 
visit the hospitals at 12 and 24 weeks after the abortion to 
meet women’s needs on FP. 
Intervention Group 2: Standard PAFP Package + incentive 
mechanismto service providers
•	 Beside the standard PAFP Package used in intervention 
group 2, the financial incentive to service providers will be 
proposed in order to strengthen their motivation and to en-
sure quality of care. 
•	 Such as the inclusion of PAFP service provision in institu-
tional and provider’s assessment criteria, bonus or income 
to doctors or nurses, job promotion, etc. This accountability 
mechanism will be integrated into existing hospital manage-
ment system, it might vary among participating hospitals. 
This intervention will be reached through the advocating the 
hospital’s managers and supervision mechanism. 
Group 3: Control group
•	 Care given as usual without any intervention.
Trial processes and quality control
Trainers from universities or hospitals who are FP experts will 
provide special sessions of in-service training on PAFP services 
to the abortion service providers and hospital/department man-
agers from hospitals allocated in intervention group 1 and group 
2. Guidelines for health managers and service providers will be 
introduced. The technical support will be available during the 
whole study period.
A set of training evaluation strategies will be developed in order 
to ensure the quality of training, such as pre- and post- training 
tests and interactive communication between trainers and train-
ees during and after training sessions. 
During the study period, some additional qualitative informa-
tion will be collected by the monitors who are responsible for 
the monitoring of intervention implementation at each hospital:
•	 Technical contents of the information provided to trainees
•	 Quality of the interpersonal communication between trainers 
and trainees at sub-sample
These monitors will spend several days in the selected hospitals 
for observing and monitoring the training process and evaluate 
in clinical practice (e.g., service provider - patient interactions 
when given the informed consent, answering questions, etc.). 
Although, such observation may be subject to the Hawthorne ef-
fect (also called observer effect whereby providers change their 
behaviour when observed), but it has still been found to provide 
valuable information on the purpose of improving service provi-
sion in other settings. The prompt feedback will be discussed 
with the trainers and the project consortium to develop strategy 
enhancing the implementation.
Prior to participation, each hospital will be contacted by the Na-
tional Coordinator or their nominated deputy. Study design of 
INPAC project and the interventions approaches as well as the 
data collection instrument will be informed to hospital/depart-
ment managers and the persons in charge of the study. 
The implementation of intervention packages is planned to start 
from April 01, 2014. All participants is planned to be followed 
up at month 1, month 3 and month 6 after their enrolment. The 
intervention implementation will be supervised and monitored 
by provincial coordinators in each province under direction of 
national coordinators. The regular implementation supervision, 
monitoring and quality control during the implementation period 
will be conducted by national coordinators and project leader. 
OUTCOME
Primary Outcome
The primary outcome includes the following indicators:
1. Unintended pregnancies including clinical or self-reported 
unintended pregnancies at the time of follow-up interviews.
2. Repeat induced abortions induced abortion and ongoing preg-
nancies that women did not want to give birth to a baby among 
all follow-up women during the follow-up period. 
3. Use of modern contraceptive methods including OCP, IUDs, 
implants, male/female condoms, others barrier methods (such 
as diaphragms, the cervical cap and spermicides), emergency 
contraception, sterilisation (male/female) during follow-up 
period.
Secondary Outcome
1. Immediate contraceptive uptake: including IUD, OCP, steril-
ization, injection, implant, etc.
2. Contraceptive practices: use of any contraceptive methods, 
including condom, natural methods (periodic abstinence or 
withdrawal), IUDs, OCP, EC, sterilization, injection, implants, 
diaphragm, spermicide, etc. during follow-up period. 
3. Consistent use, correct use, and both consistent and correct 
use of condom among condom users during the follow-up pe-
riod.
4. Changes in knowledge and attitudes about the risk of unin-
tended pregnancies.
5. Morbidity/mortality related to abortion 
6. Sexually transmitted infections (including HIV)
7. Satisfaction regarding abortion and family planning services.
8. Post-abortion family planning services received during abor-
tion services among all participants, including group education, 
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individual counselling, free contraceptives and referral to other 
family planning services. 
9. Pregnancies among all follow-up women during the follow-
up period.
10. Reported direct cost related to the abortion
Participant timeline 
Figure 1 shows the flow of the enrolment, interventions and as-
sessment. 


















Random selection of 90 hospitals
 (3 hospitals/province* 30 provinces) 
Random allocation of 90 participating hospitals
30 hospitals intervention group 1 30 hospitals in intervention group 2 30 hospitals in control group
Training to trainers + 
free contraception available  
Training to trainers + 
free contraception available  No action
Assessment of womens’ eligibility Assessment of womens’ eligibility Assessment of womens’ eligibility
Participant to sign consent form Participant to sign consent form Participant to sign consent form
Baseline survey at month 0 Baseline survey at month 0 Baseline survey at month 0
Subjects will receive Standard PAFP 
intervention
Subjects will receive Standard PAFP 
intervention+incentive mechanism to 
service providers
Subjects will receive care as usual 
without any intervention
Questionnaire survey + follow-up 
counselling
Questionnaire survey + follow-up 
counselling Questionnaire survey only
Questionnaire survey only
Questionnaire survey only
Questionnaire survey + follow-up 
counselling+ SMS
Questionnaire survey + follow-up 
counselling+ SMS
Analysis
Exclude from analysis with reason
Analysis
Exclude from analysis with reason
Analysis
Exclude from analysis with reason
Figure 1: Participant timeline.
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Sample size estimation
This isa three–arm trial, there are two alternative intervention 
arms (group 1 and group 2), the expected difference of outcome 
between intervention group 1 and group 2 would be smaller than 
the expected difference between either of the two study arms and 
the control arm.The sample size calculation was based on the 
comparison of two intervention arms for getting large sample 
which could provide adequate power for comparisons between 
either of two intervention groups and the control group.
Sample size calculation was used the methods proposed by Don-
ner and Klar.22
•	 When the reduction of repeat induced abortion rate as the 
measurement of effect.Taking into account the intra-cluster 
correlation coefficient (r) as 0,0223 with 80% of power, a 
2-sided significance level of 5%, and an average cluster size 
of 100 women, minimum 84 clusters (28 in each arm of the 
trial) were required to detect the decreased repeat abortion 
rate from 3.5% to 1.5%18 where the inflation factor [1 + (m–
1) r] is 2,98. A follow-up survey will be designed to be con-
ducted after 6 months of the abortion. Given 50% drop-out 
of target population, an average of 200 abortions will be re-
quired for each participating hospital.Taking into account the 
province as the stratification factor, three hospitals in each 
province will be recruited and allocated, a total of ninety hos-
pitals (30 in each arm) will participate in the study. 
•	 When the increased modern contraceptive use as the mea-
surement of effect. Taking into account the intra-cluster cor-
relation coefficient (r) as 0,0223 with 80% ofpower, a 2-sided 
significance level of 5%, and an average cluster size of 100 
women, minimum 36 clusters (12 in each arm of the trial) 
were required to detect the increased use of modern contra-
ceptive methods from 53-63%.24 Given drop-out of target 
population with 50%, an average of 200 abortions will be 
required for each participating hospital.
Recruitment
We first developed the hospital sampling frame from 30 prov-
inces that met the eligibility criteria based on the results of a 
cross-section survey conducted one year early. Each province 
provided a list of 12 eligible hospitals except three provinces 
(Ningxia, Qinghai and Inner Mongolia), where they were only 
able to provide 6 hospitals due to the limited available number of 
eligible hospitals in those low-income regions. Three hospitals 
in each province were randomly selected for inviting participa-
tion in study. Women who seek abortion at participating hospi-
tals and meet the inclusion criteria will be invited for participat-
ing study. All the women visiting the participating hospitals will 
receive normal services regardless of their participation condi-
tions.
Randomisation and Allocation
Random selection of participating hospital
Randomisation will be performed by the Aarhus University - 
Danish Epidemiology Science Centre (AU-DESC), Denmark.
A stratified design will be used to ensure that the three arms of 
the trial are as similar as possible at baseline. The stratification 
factor is province. Eligible hospitals will be listed in each prov-
ince and provided to AU-DESC where 3 participating hospitals 
will be selected randomly.
Allocation sequence
The 90 hospitals will be divided into 30 blocks with 3 hospitals 
in each block using hospital size/type and locations matching 
criteria. Each block will be numbered 1 to 30 and each hospi-
tal within the block will be numbered 1, 2 or 3. The notation 
15-2 means the second hospital in block 15 (range 1-1, …..30-
3). Each arm will be labelled A, B and C. The order of hospitals 
within a block does not matter but it has to be done before the 
start of randomizing to the arms.
Randomisation to each arm A, B or C is then based on first ap-
pearance of the numbers 1,2 or 3 in a sequence of one digit ran-
dom numbers, started at a random place on the list. If that first 
number is 2, the second hospital will be allocated to arm A in 
that block. If the second random number is 3 that hospital is ran-
domized to arm B and hospital number 1 is then allocated to arm 
C. All hospitals within a block have to be randomized before the 
next block is was processed.
A detailed log file will be kept under lock for the randomization 
identifying the blocks and which arm each hospital was allo-
cated to. The file should include the name of the one who did the 
randomization and who controlled the process – including dates 
and signatures.
Information on the allocation will not be provided before all 
hospitals are allocated. No change in allocation is allowed. A 
failure to accept the treatment allocation is considered as non-
compliance to the protocol. The hospital is included in the inten-
tion to treat analysis.
Blinding
Due to the nature of the intervention neither participants (women) 
nor health providers can be blinded to allocation, the researchers 
who will analysis data will not be informedthe allocation status 
prior the analysis by using pre-coding system in the database. 
Data Collection
Data collection will be conducted at 4-points during the study 
period:time of women seeking abortion before intervention im-
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plementation (M0); 1 month after abortion (M 1); 3 months after 
abortion (M3) and 6 months after abortion (M6).
The M0 data will be presented as ‘baseline’ data, which will de-
scribe the characteristics of women in the participating hospitals 
immediately before trial entry, and the characteristic of abortion 
distribution in the hospitals.The ‘outcome’ data will describe the 
outcomes of the women undergone abortion during the follow-
up period at month 3rd and month 6th after the abortion.
All abortion-seeking women who visited the selected hospitals 
will be collected about their socio-demographic information, 
contraceptive practices 3-6 months before abortion (history of 
contraception), contraceptive knowledge, reproductive history, 
and family planning services they received during their abortion 
at the hospital. 
At the 1st, 3rd and the 6th month followed the abortion, all the 
participants will be asked about their contraceptive practices and 
if there is any unintended pregnancy and induced abortion hap-
pened after enrolment (follow-up interview: mostly telephone 
interview). 
Structured questionnaires will be used to collect baseline and 
follow-up data.
Questionnaires for the follow-up period are slightly modified to 
capture the received intervention and its effect. Interviews will 
not blind to interviewers regarding intervention packages pro-
vided to the women. Interviews can be done by telephone or 
face-to face methods. 
Analysis
The analysis of the trial will be by ‘intention-to-treat’, regard-
less of the management received by individual women in the 
trial. The sensitivity analyses will be conducted for evaluate bias 
related to missing data at the endpoint. Statistical analyses will 
be reported in accordance with the CONSORT guidelines for 
cluster RCTs.25
Analyses will be performed at individual level after adjusting 
the effect of clustering. Descriptive statistics (means and pro-
portions) will be calculated to check for any major imbalances 
between the trial arms at baseline. The methods proposed by 
Donner and Klar,22 will be used to compare the rate of the pri-
mary and secondary outcomes between the study groups con-
trolling for the stratification variables. The level of statistical 
significance for the analysis will be p<0.05 (two sided). Odds 
ratios and 95% confidence intervals, adjusted for the effect of 
clustering, will be calculated to determine the magnitude of any 
differences in outcomes between the trial arms. 
This study is not expected to carry any risk neither to the wom-
en, nor at hospital level, thus will no formal interim analysis be 
performed. 
ETHICAL APPROVAL AND CONSENT 
This study has received ethical approval from the Ethical 
Committees at Ghent University, Belgium on 26 May 2014 
(B670201421116) and National Research Institute for Family 
Planning, China (6 March 2014). The individual participant con-
sent will be provided in Chinese and sought in all cases.
Trial Monitoring (Roles and Responsibilities)
Trial implementation and organization
Trial Steering Committee (TSC)
The trial Steering Committee comprises the INPAC project man-
agement team (PMT):
ICRH-UG, Belgium: Marleen Temmerman, Wei-Hong Zhang; 
CMA-CSFP, Beijing, China: Jian Li; FU, Shanghai, China: Xu 
Qian; NRIFP, Beijing, China: Shangchun Wu; SCU, China: Lina 
Hu; AU-DESC, Aarhus, Denmark: Jørn Olsen; LSTM, Liver-
pool, United Kingdom: Rachel Tolhurst.
The specific tasks of the Steering Committee will be the follow-
ing:
•	 To approve the main study protocol
•	 To approve necessary changes in the protocol based on con-
siderations of feasibility and practicability
•	 To resolve problems brought to it by the NCo team
•	 To approve study reports and papers for publication
•	 To ensuringthe implementation in compliance with the pro-
tocol
National Co-ordination (NCo)
The trial will be managed by CMA-CSFP team.
The responsibilities of NCo include the following:
•	 Identification of the eligible hospital listings 
•	 Recruitment of participating hospitals
•	 Where relevant translation of the protocol and the other 
appropriate document into local language(s)
•	 Distribution and supply of data collection forms and other 
appropriate trial documentations to the provincial coordi-
nators
•	 Field visits for monitoring the study progress and data col-
lection process
•	 Data collection (via the provincial co-ordinations) and 
management
•	 Data entry except where provincial/hospital team prefer to 
transfer the electronic data and data cleaning 
Provincial Co-ordination (PCo) 
The responsibilities of PCo include the following:
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•	 Recruitment of participating centres
•	 Distribution and supply of data collection forms to each 
hospital and other appropriate trial documentations
•	 Link between NCo and HCoData collection and cleaning 
and quality control
Hospital Co-ordination (HCo)
A local medical doctor and/or a local midwife/nurse or 1-2 medi-
cal doctors will be appointed as co-ordinator(s) in each partici-
pating hospital by NCo. 
The responsibilities of the HCos will be the following:
•	 Data collection at the four time points and be the first line of 
data quality control
•	 Be familiar with the trial
•	 Liaise with the National/provincial Co-ordinating centre
•	 Ensure that all staff involved in the study are informed about 
the trial 
•	 Ensure that supplies of data collection forms are always 
available, that they are correctly completed and returned to 
the National Co-ordinating centre timely, and to deal with 
any queries arising
•	 Facilitate other aspects of local collaboration as appropriate
•	 Make all data available for verification, audit and inspection 
purposes as necessary
•	 Ensure that the confidentiality of all information about trial 
participants is respected by all persons
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